Gilead’s experimental drug remdesivir shows possibly the most promise of all experimental COVID-19 vaccine prospects as evidenced by China’s reported possible move, via the Wuhan Institute of Virology of the Chinese Academy of Sciences, to patent the drug to treat...
Patents
Category
$3+ Billion Revenue TRUVADA and the Interesting Patent Question Few Knew About
The price of drugs becomes more contentious as some classes of drugs increase in price far faster than prevailing incomes. This overall trend appears to intensify with specialized new therapy classes, such as gene therapy where Novartis recently announced a $2 million...